Evidence map›Paper›PMID 40192851›Full record

ReviewCellular and molecular life sciences : CMLS2025

Mosquito immune responses to Plasmodium parasites that limit malaria transmission.

Ana Beatriz F Barletta, Carolina Barillas-Mury, Alvaro Molina-Cruz

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. MaRNAV-1, an intracellular virus ofbioRxiv : the preprint server for biology · 2026
    Article
  4. Evolutionary Trajectory ofBiomedicines · 2025
    Review
  5. Comparative immunological roles of TEP1 inFrontiers in immunology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ana Beatriz F Barletta *Laboratory of Malaria and Vector Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, 20852, USA. anabeatriz.barlettaferreira@nih.gov.ORCID http://orcid.org/0000-0001-9913-3775
Carolina Barillas-Mury *Laboratory of Malaria and Vector Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, 20852, USA.ORCID http://orcid.org/0000-0002-4039-6199
Alvaro Molina-Cruz *Laboratory of Malaria and Vector Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, 20852, USA. amolina-cruz@niaid.nih.gov.ORCID http://orcid.org/0000-0001-5137-4836

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The mosquito immune system is a major barrier that malaria parasites must overcome for their successful development and disease transmission. At each developmental stage in the vector, Plasmodium parasites can be potentially targeted by the mosquito innate immune responses, which involve epithelial, humoral, and cellular components. The immune response to Plasmodium ookinetes can be powerful and some of the underlying effector mechanisms are well characterized. However, the defense responses to oocysts and sporozoites appear to be less effective and are less well understood. Plasmodium parasites are under constant pressure to avoid elimination by evading and/or manipulating the mosquito immune system. Understanding the intricate interaction between Plasmodium parasites and the mosquito immune system is fundamental to understand the epidemiology of malaria transmission and to devise innovative control strategies.

Indexed as

CulicidaeMalariaMosquito VectorsPlasmodiumAnimalsHost-Parasite InteractionsHumansImmunity, InnateSporozoitesMalaria transmissionMosquitoMosquito immune responsePlasmodiumPlasmodium mosquito interaction

Identifiers

PMID40192851
PMCPMC11977068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.